CAL
ETNB

Capital Advisors Ltd’s 89bio ETNB Stock Holding History

Capital Advisors Ltd’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-798
Closed -$12K – 1415
2025
Q3 		$12K Hold
798
– – ﹤0.01% 758
2025
Q2 		$8K Hold
798
– – ﹤0.01% 839
2025
Q1 		$6K Hold
798
– – ﹤0.01% 880
2024
Q4 		$6K Hold
798
– – ﹤0.01% 904
2024
Q3 		$6K Hold
798
– – ﹤0.01% 882
2024
Q2 		$6K Hold
798
– – ﹤0.01% 869
2024
Q1 		$9K Hold
798
– – ﹤0.01% 733
2023
Q4 		$9K Hold
798
– – ﹤0.01% 704
2023
Q3 		$12K Hold
798
– – ﹤0.01% 646
2023
Q2 		$15K Hold
798
– – ﹤0.01% 613
2023
Q1 		$12K Hold
798
– – ﹤0.01% 526
2022
Q4 		$10K Hold
798
– – ﹤0.01% 558
2022
Q3 		$5K Hold
798
– – ﹤0.01% 628
2022
Q2 		$3K Buy
+798
New +$2.41K ﹤0.01% 619

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capital Advisors Ltd's ETNB Position: Q4 2025 in Review

Capital Advisors Ltd sold out of 89bio (ETNB) in Q4 2025, closing a stake of 798 shares — an estimated $12K sold.

Capital Advisors Ltd first reported a position in ETNB in Q2 2022 and held it in 14 quarters. The position peaked at $15K in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Capital Advisors Ltd reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 798 89bio shares in Q4 2025, an estimated $12K.
  • Capital Advisors Ltd first reported a position in 89bio in Q2 2022 and held it in 14 quarters.
  • Capital Advisors Ltd's 89bio position peaked at $15K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Capital Advisors Ltd's 13F filing for Q4 2025, filed 21 Jan 2026.